Anticoagulation in patients with atrial fibrillation and chronic kidney disease: clinical complexity beyond thromboembolism

被引：0
|
作者：
Buoninfante, Giovanni [1 ]
Basili, Stefania [1 ]
Romiti, Giulio Francesco [1 ,2 ,3 ]
机构：
[1] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy
[2] Liverpool John Moores Univ, Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, England
[3] Liverpool Heart & Chest Hosp, Liverpool, England
来源：
INTERNAL AND EMERGENCY MEDICINE | 2024年 / 19卷 / 07期
关键词：
D O I：
10.1007/s11739-024-03733-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1797 / 1799
页数：3
相关论文
共 50 条
  • [21] Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease
    Garlo, Katherine G.
    Steele, David J. R.
    Nigwekar, Sagar U.
    Chan, Kevin E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (01): : 125 - 136
  • [22] Atrial Fibrillation in Patients with Chronic Kidney Disease
    Kotalczyk, Agnieszka
    Ding, Wern Yew
    Wong, Christopher F.
    Rao, Anirudh
    Gupta, Dhiraj
    Lip, Gregory Y. H.
    CARDIOLOGY CLINICS, 2021, 39 (03) : 435 - 446
  • [23] Risks of anticoagulation in patients with chronic kidney disease and atrial fibrillation: More than just bleeding?
    Gutierrez, Orlando M.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2019, 3 (02) : 147 - 148
  • [24] Anticoagulation in patients with non-valvular atrial fibrillation (nvAF) and chronic kidney disease (CKD)
    Zeymer, Uwe
    Bonnemeier, Hendrik
    Wanner, Christoph
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (23) : 1642 - 1649
  • [25] Moderate chronic kidney disease contributes to major bleeding event in patients with atrial fibrillation on anticoagulation
    Nakamura, R.
    Matsue, Y.
    Mizukami, A.
    Ohno, M.
    Suzuki, M.
    Matsumura, A.
    Hashimoto, Y.
    EUROPEAN HEART JOURNAL, 2012, 33 : 342 - 343
  • [26] Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
    Magnocavallo, Michele
    Bellasi, Antonio
    Mariani, Marco Valerio
    Fusaro, Maria
    Ravera, Maura
    Paoletti, Ernesto
    Di Iorio, Biagio
    Barbera, Vincenzo
    Della Rocca, Domenico Giovanni
    Palumbo, Roberto
    Severino, Paolo
    Lavalle, Carlo
    Di Lullo, Luca
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (01) : 1 - 18
  • [27] Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease (vol 68, pg 1452, 2016)
    Lau, Y. C.
    Proietti, M.
    Guiducci, E.
    Blann, A. D.
    Lip, G. Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (25) : 2921 - 2921
  • [28] Thromboembolism and bleeding in patients with atrial fibrillation and stage 4 chronic kidney disease: impact of biomarkers
    Matusik, Pawel T.
    Lesniak, Wiktor J.
    Heleniak, Zbigniew
    Undas, Anetta
    KARDIOLOGIA POLSKA, 2021, 79 (10) : 1086 - 1092
  • [29] Oral Anticoagulation Use in Individuals With Atrial Fibrillation and Chronic Kidney Disease: A Review
    Wing, Sara L.
    Mavrakanas, Thomas A.
    Harel, Ziv
    SEMINARS IN NEPHROLOGY, 2024, 44 (02)
  • [30] Anticoagulation, atrial fibrillation, and chronic kidney disease-whose side are you on?
    Heine, Gunnar Henrik
    Brandenburg, Vincent
    KIDNEY INTERNATIONAL, 2017, 91 (04) : 778 - 780
12345